CD137 Polyclonal Antibody
- 货号：YT0722
- 应用：WB;IF;ELISA
- 种属：Human;Rat;Mouse;
- 简介：
- >>Cytokine-cytokine receptor interaction
- 蛋白名称：
- Tumor necrosis factor receptor superfamily member 9
- 免疫原：
- The antiserum was produced against synthesized peptide derived from human TNFRSF9. AA range:101-150
- 特异性：
- CD137 Polyclonal Antibody detects endogenous levels of CD137 protein.
- 组成：
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 来源：
- Polyclonal, Rabbit,IgG
- 稀释：
- WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:10000. Not yet tested in other applications.
- 纯化工艺：
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 储存：
- -15°C to -25°C/1 year(Do not lower than -25°C)
- 其他名称：
- TNFRSF9;CD137;ILA;Tumor necrosis factor receptor superfamily member 9;4-1BB ligand receptor;CDw137;T-cell antigen 4-1BB homolog;T-cell antigen ILA;CD antigen CD137
- 背景：
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB. [provided by RefSeq, Jul 2008],
- 功能：
- function:Receptor for TNFSF14/4-1BBL. Possibly active during T cell activation.,similarity:Contains 4 TNFR-Cys repeats.,subunit:Interacts with TRAF1, TRAF2 and TRAF3. Interacts with LRR-repeat protein 1/LRR-1.,tissue specificity:Expressed on the surface of activated T-cells.,
- 细胞定位：
- Membrane; Single-pass type I membrane protein.
- 组织表达：
- Expressed on the surface of activated T-cells.
- Western Blot analysis of mouse-brain cells using CD137 Polyclonal Antibody diluted at 1:500
- Western blot analysis of lysates from K562 cells, using TNFRSF9 Antibody. The lane on the right is blocked with the synthesized peptide.
